Literature DB >> 20719907

A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing, People's Republic of China.

Changdong Li1, Minghui Wu, Jiandong Wang, Songwen Zhang, Li Zhu, Jing Pan, Weiyuan Zhang.   

Abstract

BACKGROUND: Few population-based studies have investigated premalignant and malignant cervical abnormalities in Beijing.
METHODS: A total of 6,385 randomly selected sexually active women were interviewed and examined. Cervical lesion was diagnosed using cytology and histology. High-risk human papillomavirus (HPV) was detected by the second-generation hybrid capture test and typed by gene chip of DNA from paraffin-embedded tissue.
RESULTS: The cervical lesion prevalence diagnosed by histology was 5.8%. High-risk HPV overall prevalence was 9.9%, 50.5% with cervical lesion and 7.4% without cervical lesion. High-risk HPV DNA load increased with increasing degree of lesions. HPV 16 was the most common type (26.5%) among women with cervical lesion, followed by HPV 58 (8.8%), HPV 33 (7.8%), and HPV 56 (5.3%). Women under 50 years of age, married status, pregnancy and delivery status, couple's sexual behavior, contraceptive history, columnar ectopy, and bacterial vaginosis or trichomonas vaginitis history were more risk factors for HPV infection. Factors for cervical lesion were similar, but in comparison with HPV infection, all associations were weakened. Only middle-aged women, husband's sexual partners, oral contraceptives, columnar ectopy, and history of trichomonas vaginitis remained associated with cervical lesion.
CONCLUSION: In Beijing, the prevalence of cervical lesion and high-risk HPV is higher than estimated in previous reports. HPV 16, 58, and 33 were the most prevalent types. This is relevant for work related to cervical cancer vaccination. IMPACT: The study was conducted to understand the current status and epidemiologic characteristics of women with cervical lesion and HPV infection in Beijing. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20719907     DOI: 10.1158/1055-9965.EPI-10-0212

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Authors:  Xin Wang; Mei Qi; Xiuping Yu; Yan Yuan; Weiming Zhao
Journal:  J Gen Virol       Date:  2012-03-21       Impact factor: 3.891

2.  Visual detection of high-risk human papillomavirus genotypes 16, 18, 45, 52, and 58 by loop-mediated isothermal amplification with hydroxynaphthol blue dye.

Authors:  Le Luo; Kai Nie; Meng-Jie Yang; Miao Wang; Jin Li; Chen Zhang; Hong-Tu Liu; Xue-Jun Ma
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

3.  Epidemiology and treatment of trichomoniasis.

Authors:  Patricia Kissinger
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

4.  Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.

Authors:  Monserrat Balanda; Andrea Quiero; Nicolás Vergara; Gloria Espinoza; Héctor San Martín; Giovanna Rojas; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

5.  Association between Trichomonas vaginalis infection and cervical lesions: a population-based, nested case-control study in Taiwan.

Authors:  Ruei-Yu Su; Li-Ju Ho; Hung-Yi Yang; Chi-Hsiang Chung; Sung-Sen Yang; Cheng-Yi Cheng; Wu-Chien Chien; Hsin-Chung Lin
Journal:  Parasitol Res       Date:  2020-06-24       Impact factor: 2.289

6.  Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies.

Authors:  Fang-Hui Zhao; Adam K Lewkowitz; Shang-Ying Hu; Feng Chen; Long-Yu Li; Qing-Ming Zhang; Rui-Fang Wu; Chang-Qing Li; Li-Hui Wei; Ai-Di Xu; Wen-Hua Zhang; Qin-Jing Pan; Xun Zhang; Jerome L Belinson; John W Sellors; Jennifer S Smith; You-Lin Qiao; Silvia Franceschi
Journal:  Int J Cancer       Date:  2012-04-24       Impact factor: 7.396

Review 7.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

8.  Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China.

Authors:  Qingfeng Mai; Xiaohan Yang; Huan Cheng; Genghang Wu; Zikun Wu
Journal:  Hum Vaccin Immunother       Date:  2020-09-22       Impact factor: 3.452

9.  Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China.

Authors:  Qiang Chen; Long-Xu Xie; Zhi-Rong Qing; Lie-Jun Li; Zhao-Yun Luo; Min Lin; Shi-Ming Zhang; Wen-Zhou Chen; Bing-Zhong Lin; Qi-Li Lin; Hui Li; Wei-Pian Chen; Pei-Yao Zheng; Ling-Zhi Mao; Chan-Yu Chen; Chun Yang; Yong-Zhong Zhan; Xiang-Zhi Liu; Jia-Kun Zheng; Li-Ye Yang
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

10.  Evaluation of Association between Vaginal Infections and High-Risk Human Papillomavirus Types in Female Sex Workers in Spain.

Authors:  C Rodriguez-Cerdeira; E Sanchez-Blanco; A Alba
Journal:  ISRN Obstet Gynecol       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.